Marksans Pharma’s Goa plant has been approved by UK Medicines and Healthcare products Regulatory Agency (UK MHRA). The UK’s healthcare regulator inspected the company’s Goa plant from February 14- February 17.
Marksans Pharma is engaged in production of prescription drugs, caters in areas like oncology, gastroenterology, antidiabetic, cardiovascular, pain management, gynaecology and others.